184 related articles for article (PubMed ID: 27716513)
1. Specific expectancies are associated with symptomatic outcomes and side effect burden in a trial of chamomile extract for generalized anxiety disorder.
Keefe JR; Amsterdam J; Li QS; Soeller I; DeRubeis R; Mao JJ
J Psychiatr Res; 2017 Jan; 84():90-97. PubMed ID: 27716513
[TBL] [Abstract][Full Text] [Related]
2. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.
Keefe JR; Mao JJ; Soeller I; Li QS; Amsterdam JD
Phytomedicine; 2016 Dec; 23(14):1699-1705. PubMed ID: 27912871
[TBL] [Abstract][Full Text] [Related]
3. An exploratory study of salivary cortisol changes during chamomile extract therapy of moderate to severe generalized anxiety disorder.
Keefe JR; Guo W; Li QS; Amsterdam JD; Mao JJ
J Psychiatr Res; 2018 Jan; 96():189-195. PubMed ID: 29080520
[TBL] [Abstract][Full Text] [Related]
4. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.
Mao JJ; Xie SX; Keefe JR; Soeller I; Li QS; Amsterdam JD
Phytomedicine; 2016 Dec; 23(14):1735-1742. PubMed ID: 27912875
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.
Amsterdam JD; Li Y; Soeller I; Rockwell K; Mao JJ; Shults J
J Clin Psychopharmacol; 2009 Aug; 29(4):378-82. PubMed ID: 19593179
[TBL] [Abstract][Full Text] [Related]
6. Putative Antidepressant Effect of Chamomile (
Amsterdam JD; Li QS; Xie SX; Mao JJ
J Altern Complement Med; 2020 Sep; 26(9):813-819. PubMed ID: 31808709
[No Abstract] [Full Text] [Related]
7. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
Trials; 2015 Nov; 16():493. PubMed ID: 26527536
[TBL] [Abstract][Full Text] [Related]
8. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of generalized anxiety: new pharmacologic approaches].
Boulenger JP
Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
[TBL] [Abstract][Full Text] [Related]
10. Chamomile (Matricaria recutita) may provide antidepressant activity in anxious, depressed humans: an exploratory study.
Amsterdam JD; Shults J; Soeller I; Mao JJ; Rockwell K; Newberg AB
Altern Ther Health Med; 2012; 18(5):44-9. PubMed ID: 22894890
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: A systematic review and meta-analysis of randomized trials and quasi-randomized trials.
Hieu TH; Dibas M; Surya Dila KA; Sherif NA; Hashmi MU; Mahmoud M; Trang NTT; Abdullah L; Nghia TLB; Y MN; Hirayama K; Huy NT
Phytother Res; 2019 Jun; 33(6):1604-1615. PubMed ID: 31006899
[TBL] [Abstract][Full Text] [Related]
12. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
Volz HP; Kieser M
Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
[TBL] [Abstract][Full Text] [Related]
13. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
14. Post Hoc Analyses of Anxiety Measures in Adult Patients With Generalized Anxiety Disorder Treated With Vilazodone.
Khan A; Durgam S; Tang X; Ruth A; Mathews M; Gommoll CP
Prim Care Companion CNS Disord; 2016; 18(2):. PubMed ID: 27486544
[TBL] [Abstract][Full Text] [Related]
15. Generalized anxiety disorder (GAD): efficacy of standardized Matricaria recutita (German chamomile) extract in the treatment of generalized anxiety disorder.
Ross SM
Holist Nurs Pract; 2013; 27(6):366-8. PubMed ID: 24121702
[No Abstract] [Full Text] [Related]
16. Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: a 28-day, open-label study.
Mathew SJ; Garakani A; Reinhard JF; Oshana S; Donahue S
Clin Ther; 2008 Sep; 30(9):1658-66. PubMed ID: 18840371
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Chamomile Therapy of Generalized Anxiety Disorder: A Study Protocol for a Randomized, Double-Blind, Placebo- Controlled Trial.
Mao JJ; Li QS; Soeller I; Rockwell K; Xie SX; Amsterdam JD
J Clin Trials; 2014 Nov; 4(5):. PubMed ID: 29057164
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
19. Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States.
Rothschild AJ; Mahableshwarkar AR; Jacobsen P; Yan M; Sheehan DV
Eur Neuropsychopharmacol; 2012 Dec; 22(12):858-66. PubMed ID: 22901736
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial.
Durgam S; Gommoll C; Forero G; Nunez R; Tang X; Mathews M; Sheehan DV
J Clin Psychiatry; 2016 Dec; 77(12):1687-1694. PubMed ID: 27232052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
